Clinical Trial Update: ERG Components in Schizophrenia and Bipolar Disorder Type I

View source ↗

Summary

DiaMentis' clinical trial researching ERG components in schizophrenia and Bipolar I disorder is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Schizophrenia

Snippet

Sponsor: diaMentis Inc. | Conditions: Schizophrenia, Bipolar I Disorder | Status: ACTIVE_NOT_RECRUITING